Series will feature three unique sessions and keynote led by Velentium cybersecurity experts
HOUSTON, August 31, 2022 – Velentium, a Houston-based professional engineering firm specializing in the end-to-end design, development, manufacturing and post-market support of therapeutic and diagnostic active medical devices, today announced a partnership with BIOMEDevice Boston (Sept. 28-29 at the Boston Convention and Event Center) to host an exclusive Master Class Cybersecurity Series that will headline day two of the conference.
Hosted by Velentium’s Director of Product Security, Christopher Gates, and Senior Cybersecurity Engineer, Garrett Schumacher, the series will include three unique Master Class sessions and a keynote discussing the importance of cybersecurity in MedTech and exploring the necessary preemptive steps organizations should take during product development. These exclusive sessions will join the BIOMEDevice Boston Master Class Start-Up Series that provides one-of-a-kind learning experiences under one roof.
“We are very excited to partner with the BIOMEDevice Boston show to promote education and awareness for embedded cybersecurity,” said Velentium’s VP of Sales & Marketing, Ben Trombold. “Product security is at the core of what we do for our clients and has always been our passion. However, with the coordinated attacks and regulatory requirements increasing yearly, protecting medical devices and patients is more important now than ever. We look forward to working with everyone at the event and moving our industry forward.”
Three Master Class Sessions and Keynote
How to Align Your Development with the latest FDA Expectations (hosted by Gates at 10:30 a.m.)
- This session will discuss the new medical device cybersecurity laws and regulatory requirements, as well as review all the new manufacturer’s activities expected by the FDA, including the 41 cybersecurity deliverables. Most notably, Gates will explain how companies can add cybersecurity processes to their development lifecycle in ways that will satisfy the FDA and secure their medical device system without generating massive cost burdens or development delays.
Shifting Sands of Medical Device Cybersecurity Regulation: Past, Present and Future Implications from a Practitioner’s Perspective (hosted by Schumacher at 11:30 a.m.)
- This session will walk attendees through new and pending regulations, the evolving threat landscape, and will introduce a bevy of resources to help MDMs understand the state of the art and take proactive steps to secure their products, their business model, and their relationships with markets and regulators in the new decade of secure medical devices.
Software Supply Chain Security Mitigations for Medical Device Development (hosted by Gates at 12:30 p.m.)
- This final session will focus on supply chain attacks in medical device systems. Gates will review the environment, risks, best practices, and security mitigation tools available (including SBOMs) to enable manufacturers to secure their supply chains from threats to their customers, their patients, and their business model.
Cybersecurity: Unworkable Today, Hope for Tomorrow (Keynote hosted by Gates at 1:30 p.m.)
- To wrap up the series, Gates will host a keynote open to all attendees about one approach for how to abandon the current broken model for secure design and adopt a new approach to designing security into a company’s next medical device. This new approach aligns with the intent of regulatory standards, does not require staffing up with expensive and hard-to-find embedded cybersecurity experts, and improves the overall speed of the development process.
“It only makes sense for the best experts in medical device cybersecurity to partner with the best in awareness and education for topics in the medical device industry,” said Gates. “We look forward to a long and productive association with BIOMEDevice.”
Velentium strives to educate the healthcare industry as to what is expected and required for cybersecurity in today’s medical device manufacturing environment. This cybersecurity track is tailored for the medical device manufacturer, including project managers, system engineers, software engineers, and device developers. To learn more about Velentium, visit www.velentium.com, or register for BIOMEDevice Boston here.
About Velentium:
Velentium is a Houston-based professional engineering firm specializing in the end-to-end design, development, manufacturing and post-market support of therapeutic and diagnostic active medical devices. The company’s core competencies include active implantable medical devices, systems engineering, firmware & software, cybersecurity, mobile & cloud, electrical & mechanical engineering, human factors & usability, automated test systems, and CGMP manufacturing. With customers all over the world, Velentium has experience working with all sizes of clients, ranging from startups seeking seed funding to established Fortune 500 companies. For more information, visit www.velentium.com.
